Videos
December 10, 2020
Winston Wong, PharmD, Robin Zon, MD, FACP, FASCO, and Gordon Kuntz, discuss highlights from the 5th Annual Oncology Clinical Pathways Congress.
Videos
November 25, 2020
This session from the Oncology Clinical Pathways Congress provided a glimpse into how pathways can be adapted to address community-identified barriers to care.
Videos
November 02, 2020
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, present preliminary findings of the Care Pathways Working Group, which seeks to identify challenges and actionable solutions for stakeholders as they face the evolving design and implementation of care pathways.
Conference Coverage
October 18, 2020
This session from the Oncology Clinical Pathways Congress provided a glimpse into how pathways can be adapted to address community-identified barriers to care.
Conference Coverage
October 18, 2020
Robin T Zon, MD, FACP, FASCO, Gordon Kuntz, and Winston Wong, PharmD, presented preliminary findings of the Care Pathways Working Group, which seeks to identify challenges and actionable solutions for stakeholders as they face the evolving design and implementation of care pathways.
Conference Coverage
October 18, 2020
Sibel Blau, MD, and Ray Page, DO, PhD, FACOI, FASCO,  presented the provider perspective on value-based care and insurance design at the Oncology Clinical Pathways Congress.
Conference Coverage
October 17, 2020
With perspectives from the employer, payer, provider, and pathway vendor, this multi-part series presented examples of current value-based care programs and practical strategies to achieve greater value in cancer care delivery.

Conference Coverage
October 17, 2020
Amy Schroeder, RPh, and Roy Beveridge, MD, discuss how providers and accountable groups can align their quality and outcomes goals, as well as how the health care landscape is influencing changes in this arena.
Videos
October 16, 2020
Sonali Fonseca, PhD, demonstrates how pathways are an important tool to participate in value-based models in a predictable and sustainable manner.
Conference Coverage
October 16, 2020
Barry Russo, MBA, CEO, and Ray Page, DO, PhD, FACOI, FASCO, discusses cancer care and pathways amid the COVID-19 pandemic and strategies for how practices can adapt.
Videos
October 16, 2020
The official meeting of the Journal of Clinical Pathways, Oncology Clinical Pathways Congress remains committed to being the only dedicated gathering for oncology pathways education.
Conference Coverage
October 16, 2020
Winston Wong, PharmD, presented a brief look at results from the Oncology Clinical Pathways Benchmarking Survey at the 2020 Virtual Oncology Clinical Pathways Congress.
Videos
July 24, 2020
The Oncology Clinical Pathways Congress remains committed to being the only dedicated gathering for oncology pathways education by offering a fully virtual version of the event in light of current challenges.
Special Reports
November 19, 2019
Coverage of the 2019 Oncology Clinical Pathways Congress includes multiple interviews with faculty members and attendees, as well as detailed results of the second annual State of Clinical Pathways Survey.
Videos
November 19, 2019
Wui-Jin Koh, MD, senior vice president and chief medical officer, NCCN, explains the importance of interoperability between pathways and EHRs as well as whether NCCN is considering real-world data as an evidence source in the guidelines.
Videos
November 04, 2019
Michael Hassett, MD, MPH, shares some of the challenges of integrating the clinical pathways program at Dana-Farber Cancer Institute within the standard workflow as well as the role of technical innovation in pathway development.
Videos
October 31, 2019
Charles Saunders, MD, discusses strategies that practices succeeding in OCM have used to decrease drug costs at the Oncology Clinical Pathways Congress.
Videos
October 30, 2019
Winston Wong, PharmD, highlights what he learned at the 2019 Congress and expressed his excitement about the increasing complexity and utility of oncology pathways.
Podcast
October 29, 2019
At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
News
October 15, 2019
Alexander B Olawaiye, MD, MRCOG, FACOG, FACS, University of Pittsburgh, presented on the emergence of PARP inhibitors and the rapidly expanding evidence base for ovarian cancer treatment.
News
October 15, 2019
Alan Balch, PhD, CEO, Patient Advocate Foundation, and Mishellene McKinney, RN, MHA, OCN, Roswell Park Comprehensive Cancer Center, spoke on how pathways can support high-quality care through more than just clinical decision support on therapy choices.
News
October 12, 2019
Rick Peters, MD, UT Austin Dell Medical School, and Mahek Shah, MD, Harvard Business School, presented on the role of technology in clinical pathways and shifting the identity of pathways from a retrospective view to a real-time predictive, prospective view.
News
October 11, 2019
Pathway leaders from Moffitt Cancer Center and US Oncology Network explained how their respective pathways would guide treatment for two hypothetical patient cases and how their physicians typically interact with the pathways.
News
October 11, 2019
Winston Wong, PharmD, offered the first look at the results of the second annual clinical pathways benchmarking survey of real-world pathway stakeholders.
News
October 28, 2018
Ray D Page, DO, PhD, President & Director of Research, The Center for Cancer and Blood Disorders, tackled the challenging subject of how to define successful outcomes and demonstrate return on investment for a clinical pathways program.
Conferences
October 28, 2018
News
September 15, 2017
Clinical pathway development needs to better take into account the patient perspective of cancer care, according to Alan Balch, PhD, in a presentation at the Clinical Pathways Congress.
News
September 09, 2017
Approximately 170 million covered lives in oncology are potentially impacted by clinical pathways, representing 57% of the patient population. The American Society of Clinical Oncology (ASCO) has…
News
September 09, 2017
Biosimilars occupy a huge place in the oncology treatment conversation these days. But what are they exactly, and how will they impact clinical pathways?
News
September 09, 2017
Jennifer R Brown, MD, PhD, presented the emerging treatments and management options for front line and relapsed or refractory chronic lymphocytic leukemia today at the Clinical Pathways Congress.
October 01, 2016
A discussion about clinical pathways for non-small cell lung cancer was led by David Jackman, MD, who designed the pathways program for NSCLC at Dana Farber Cancer Instutute.
October 01, 2016
“It is time to rethink how we treat chronic lymphocytic leukemia,” said Chadi Nabhan, MD, MBA, FACP, Cardinal Health Specialty Solutions, who spoke at length about the shifting landscape of oncology care and the role of clinical pathways.
October 01, 2016
Bert H O’Neil, MD, Indiana University Simon Cancer Center, discussed some of the important factors to consider when developing a clinical pathway for colorectal cancer.
October 01, 2016
Dr Zon was joined by Andrew Hertler, MD, FACP, New Century Health, and Dr Kolodziej to discuss the Policy Statement and its implications.
October 01, 2016
In a presentation at the inaugural Clinical Pathways Congress, Dr Kolodziej argued that clinical pathways as we know them will cease to exist as a result of the rise of immunotherapies for the treatment of cancer.
October 01, 2016
Richard Schilsky, MD, senior vice president and chief medical officer of the ASCO kicked off the meeting on Friday night with his Keynote Address on the relationship between clinical pathways development and the emergence of precision medicine.